ClinicalTrials.Veeva

Menu

Mechanisms for Covid-19 Disease Complications (COVID MECH)

U

University Hospital, Akershus

Status

Unknown

Conditions

COVID
Coronavirus Infection

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Covid-19 is associated with a wide range of symptoms and clinical trajectories, and early identification of patients at risk for developing severe disease is desirable. Several risk markers and comorbidity profiles have been proposed but their relative importance in unselected patients admitted to hospital with Covid-19 remains unclear. This study aims to assess the prognostic value organ specific biomarkers, viral dynamics and immune response markers in patients infected with SARS-CoV2.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All patients >18 years of age with a positive test for SARS-CoV2 are eligble for inclusion.
  • Healty age-matched volunteers will be included as a control group

Exclusion criteria

  • None

Trial contacts and locations

1

Loading...

Central trial contact

Torbjørn Omland, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems